{"database": "lobbying", "table": "lobbying_activities", "rows": [[3481788, "11cebcd3-a9fb-4d47-9d87-3953b773f701", "Q4", "LMH STRATEGIC SOLUTIONS", 401108183, "ACADIA PHARMACEUTICALS", 2025, "fourth_quarter", "PHA", "Prescription drug payment reform. Pharmaceutical supply chain.", "Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2026-01-12T17:01:55-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3481788"], "units": {}, "query_ms": 30.716727022081614, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}